The current P/E ratio for Hologic stock as of Jul 10, 2025 is 27.97. This is calculated based on the TTM EPS of $2.39 and the stock price of $66.85 per share. The PE ratio has increased by 14% from its last 4 quarters average of 24.4.
The average historical PE ratio of Hologic for the last ten years is 30.1. The current price-to-earnings ratio of 27.97 is 7% less than the historical average. Analyzing the last ten years, HOLX's PE ratio reached its highest point in the Dec 2019 quarter at 163.63, when the price was $52.36 and the EPS was $0.32. The lowest point was recorded in the Jun 2021 quarter, when it reached 8.37 with a price of $65.89 and an EPS of $7.87.
Maximum annual increase: 208.47% in 2023
Maximum annual decrease: -79.04% in 2015
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 24.13 | -35.67% | $80.82 | $3.35 |
2023 | 37.51 | 208.47% | $69.4 | $1.85 |
2022 | 12.16 | 15.7% | $62.98 | $5.18 |
2021 | 10.51 | -30.76% | $76.48 | $7.28 |
2020 | 15.18 | N/A | $64.35 | $4.24 |
2019 | N/A | N/A | $49.61 | -$0.76 |
2018 | N/A | N/A | $40.98 | -$0.4 |
2017 | 13.59 | -58.29% | $36.69 | $2.7 |
2016 | 32.58 | -61.72% | $38.45 | $1.18 |
2015 | 85.11 | -79.04% | $40 | $0.47 |
2014 | 406 | N/A | $24.36 | $0.06 |
2013 | N/A | N/A | $20.91 | -$4.36 |
2012 | N/A | N/A | $20.22 | -$0.28 |
2011 | 26 | N/A | $15.6 | $0.6 |
2010 | N/A | N/A | $16.66 | -$0.24 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 25.66 | 12.74% | $61.32 | $2.39 |
Dec 2024 | 22.76 | -5.68% | $72.6 | $3.19 |
Sep 2024 | 24.13 | -4.13% | $80.82 | $3.35 |
Jun 2024 | 25.17 | -36.73% | $74.25 | $2.95 |
Mar 2024 | 39.78 | 18.04% | $77.96 | $1.96 |
Dec 2023 | 33.7 | -10.16% | $71.45 | $2.12 |
Sep 2023 | 37.51 | -9.2% | $69.4 | $1.85 |
Jul 2023 | 41.31 | 55.13% | $80.97 | $1.96 |
Apr 2023 | 26.63 | 40.97% | $80.7 | $3.03 |
Dec 2022 | 18.89 | 55.35% | $74.81 | $3.96 |
Sep 2022 | 12.16 | 2.7% | $62.98 | $5.18 |
Jun 2022 | 11.84 | -4.59% | $70.93 | $5.99 |
Mar 2022 | 12.41 | 9.53% | $76.05 | $6.13 |
Dec 2021 | 11.33 | 7.8% | $76.12 | $6.72 |
Sep 2021 | 10.51 | 25.57% | $76.48 | $7.28 |
The current PE ratio of HOLX is above its 5-year average, but it is under its 10-year average.
When compared to its peers GE and BSX, HOLX's PE ratio is lower, but it is higher than JNJ's and ABT's. Hologic's PE ratio is trading below the peer average of 32.83.
Stock name | PE ratio | Market cap |
---|---|---|
ABT Abbott Laboratories | 17.31 | $232.44B |
JNJ Johnson & Johnson | 17.41 | $379.41B |
DGX Quest Diagnostics Inc | 21.4 | $19.14B |
TMO Thermo Fisher Scientific Inc | 25.2 | $162.6B |
HOLX Hologic Inc | 27.97 | $14.9B |
BDX Becton Dickinson & Co | 34.27 | $50.87B |
GE General Electric Co | 38.98 | $269.34B |
BSX Boston Scientific Corp | 75.26 | $153.66B |
HOLX's price to earnings ratio is 27.97 as of Jul 10, 2025.
Over the last 3 years, the average PE ratio for HOLX stock is 27.97.
Over the last 5 years, the average PE ratio for HOLX stock is 21.13.
Over the last ten years, the Dec 2019 quarter recorded the highest quarterly PE ratio at 163.63.
The current PE ratio of HOLX is 7% lower than the 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jul 10, 2025), Hologic's share price is $66.85. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $2.39. Therefore, Hologic's price to earnings ratio for today is 27.97. PE RATIO(27.97) = STOCK PRICE($66.85) / TTM EPS($2.39)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.